OpGen, Inc. (OPGN)
OTCMKTS · Delayed Price · Currency is USD
0.0002
0.00 (0.00%)
Oct 29, 2025, 4:00 PM EDT
OpGen Market Cap
OpGen has a market cap or net worth of $2.01 thousand as of October 30, 2025. Its market cap has decreased by -99.95% in one year.
Market Cap
2.01K
Enterprise Value
870.66K
Revenue
5.03M
Ranking
n/a
PE Ratio
0.00
Stock Price
$0.00
Market Cap Chart
Since May 5, 2015, OpGen's market cap has decreased from 51.90M to 2.01K, a decrease of -100.00%. That is a compound annual growth rate of -62.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2025 | 2.01K | -99.97% |
| Dec 31, 2024 | 5.99M | 42.44% |
| Dec 29, 2023 | 4.21M | -44.45% |
| Dec 30, 2022 | 7.57M | -80.56% |
| Dec 31, 2021 | 38.95M | -15.10% |
| Dec 31, 2020 | 45.88M | 1,069.17% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 815.18M |
| Elite Pharmaceuticals | 648.67M |
| Glass House Brands | 563.30M |
| Northwest Biotherapeutics | 355.88M |
| Silence Therapeutics | 341.50M |
| Nika Pharmaceuticals | 312.10M |
| CytoDyn | 303.60M |
| American Oncology Network | 297.14M |